GLP-1RAs, including exendin-4, lixisenatide, liraglutide, semaglutide, and various GLP-1 fragments, provide comprehensive protective effects against atherosclerosis across multiple stages of plaque development [116] (see Table 1). This evidence concerns the gene GCG and atherosclerosis.